Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMed

Cell-Penetrating Peptide-Mediated Modulation of Endoplasmic Reticulum Stress: A Bioengineered and Translational Approach.

Paliwal T., Joshi R., Paliwal S., Chakraborty D., Sharma S.

Narrative Review on Type 2 Diabetes, Chronic Inflammation, published in ACS Pharmacol Transl Sci (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
ACS Pharmacol Transl Sci (2026)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
42312171
PMCID
PMC13270369
DOI
10.1021/acsptsci.5c00742

Abstract (original English)

Endoplasmic reticulum (ER) stress is central to the onset and progression of metabolic and inflammatory disorders, such as insulin resistance, hepatic steatosis, and cardiovascular dysfunction. The unfolded protein response, triggered by ER stress, induces maladaptive pathways through PERK, IRE1, and ATF6, leading to inflammation, apoptosis, and cellular dysfunction. Targeted ER stress modulation is an attractive therapeutic approach, and recent developments in bioengineering have enabled precise delivery of modulatory agents using cell-penetrating peptides and adipose-derived stem cells. On the one hand, cell-penetrating peptides (CPPs) enable intracellular delivery of therapeutic cargoes such as siRNA, peptides, or small-molecule targeting key ER stress mediators, including CHOP, GRP78, IRE1, and NF-κB. CPP-mediated delivery systems restore ER homeostasis, reduce inflammatory signaling, and improve cellular survival in hepatocytes, pancreatic β-cells, and cardiomyocytes. Simultaneously, adipose tissue-derived stem cells (ADSCs), which are derived from lipo-aspirated fat tissue, induce paracrine effects through the secretion of anti-inflammatory cytokines (i.e., IL-10), growth factors (i.e., VEGF, HGF, TGF-β), and antioxidants that regulate ER stress responses. ADSCs also have adipogenic and endothelial differentiation, playing roles in repairing tissue and metabolic homeostas

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research